Sandip Kapadia, CHIEF FINANCIAL OFFICER at Harmony Biosciences Holdings, Inc. (HRMY), sold 3,746 shares at $37.15 ($139K) on 2026-01-26, disclosed to the SEC on 2026-01-28.
Scheduled sale ($139k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HRMY | SELL | 2025-11-25 | $120K | — | Filing → |
| HRMY | SELL | 2025-08-19 | $1.6M | — | Filing → |
| HRMY | SELL | 2025-04-03 | $430K | — | Filing → |